Status:
UNKNOWN
Utility of Lactoferrin as a Preventive Agent for Healthcare Workers Exposed to COVID-19
Lead Sponsor:
Cairo University
Conditions:
COVID-19
Eligibility:
All Genders
18-65 years
Phase:
PHASE2
PHASE3
Brief Summary
COVID 19, which probably started from zoonotic transmission related to crowded markets in China was announced as a pandemic by the WHO on 11 March 2020. There is currently no clinically proven specif...
Detailed Description
In December, 2019, an outbreak of pneumonia with unknown cause occurred in Wuhan city, in China. On January 7th, the scientists succeeded to isolate a novel coronavirus, severe acute respiratory syndr...
Eligibility Criteria
Inclusion
- health care workers at risk of SARS-CoV-2 transmission with no previous diagnosis of SARS-CoV-2 infection
- No symptoms compatible with SARS-CoV-2 (COVID-19) until the date of enrolment in the study.
Exclusion
- Known allergy or hypersensitivity to the used medications
Key Trial Info
Start Date :
July 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 1 2020
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT04427865
Start Date
July 1 2020
End Date
November 1 2020
Last Update
June 16 2020
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.